Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Liraglutide in Newly Onset Type 1 Diabetes. (NewLira)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01879917
Recruitment Status : Active, not recruiting
First Posted : June 18, 2013
Last Update Posted : December 12, 2018
Steno Diabetes Center Copenhagen
Hillerod Hospital, Denmark
Bispebjerg Hospital
Odense University Hospital
Aarhus University Hospital
Aalborg University Hospital
Hospital of South West Denmark
Information provided by (Responsible Party):
Thomas Dejgaard, Hvidovre University Hospital

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : November 2018
Estimated Study Completion Date : December 2018